Latest News about CRBU
Recent news which mentions CRBU
Stocks That Hit 52-Week Lows On Friday
April 08, 2022
From Benzinga
How to future-proof your stock investments and outperform the market at the same timesystemic risk and societal collapse
March 25, 2022
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022
February 18, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2022
February 14, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
5 Penny Stocks Insiders Are Buying
December 09, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
December 01, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
November 30, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 22, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 15, 2021
November 15, 2021
From Benzinga
2 Penny Stocks Insiders Are Buying
October 22, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 14, 2021
From Benzinga
35 Biggest Movers From Friday
October 11, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
From Benzinga
28 Stocks Moving In Friday's Mid-Day Session
October 08, 2021
From Benzinga
Breaking Down CRISPR Technology
September 28, 2021
From Motley Fool
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
From Motley Fool
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
September 08, 2021
From Benzinga
Could CRISPR Therapeutics Stock Help You Retire a Millionaire?
August 31, 2021
From Motley Fool
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 19, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 17, 2021
August 17, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
From Benzinga
68 Biggest Movers From Yesterday
August 10, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 06, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.